Roberto Corti

Showing 1-14 of 14 articles

Impact of mitral regurgitation aetiology on MitraClip outcomes: the MitraSwiss registry

Sürder D, Klersy C, Corti R, Biasco L, Gaemperli O, Maisano F, Toggweiler S, Jeger R, Naegeli B, Noble S, Biaggi P, Moccetti T, Pedrazzini G

June 12, 2020 | 10.4244/EIJ-D-19-00718

Coronary interventions

Switzerland: coronary and structural heart interventions from 2010 to 2015

Rigamonti F, Fahrni G, Maeder M, Cook S, Weilenmann D, Wenaweser P, Rothlisberger C, Corti R, Rickli H, Kaiser C, Roffi M

May 15, 2017 | 10.4244/EIJ-D-16-00828

Coronary interventions

First-in-man six-month results of a surface-modified coronary stent system in native coronary stenosis

Suwannasom P, Sotomi Y, Corti R, Kurz D, Roffi M, von Birgelen C, Buzzi S, Zucker A, Dijkstra J, Wykrzykowska J, de Winter R, Windecker S, Onuma Y, Serruys P, Daemen J, Räber L

April 20, 2017 | 10.4244/EIJ-D-16-00975

Interventions for valvular disease

First-in-man transfemoral transcatheter aortic valve implantation with the ACURATE neo for the treatment of aortic regurgitation

Toggweiler S, Biaggi P, Grünenfelder J, Reho I, Bühler I, Corti R

May 16, 2016 | 10.4244/EIJV12I1A14

Interventions for valvular disease

The 2011-2012 pilot European Society of Cardiology Sentinel Registry of Transcatheter Aortic Valve Implantation: 12-month clinical outcomes

Gilard M, Schlüter M, Snow T, Dall’Ara G, Eltchaninoff H, Moat N, Goicolea J, Ussia G, Kala P, Wenaweser P, Zembala M, Nickenig G, Price S, Barrero E, Iung B, Zamorano P, Schuler G, Corti R, Alfieri O, Prendergast B, Ludman P, Windecker S, Sabaté M, Witkowski A, Danenberg H, Schroeder E, Romeo F, Macaya C, Derumeaux G, Laroche C, Pighi M, Serdoz R, Di Mario C

May 16, 2016 | 10.4244/EIJV12I1A15

Interventions for valvular disease

Impact of percutaneous mitral valve repair using the MitraClip system on tricuspid regurgitation

Frangieh A, Gruner C, Mikulicic F, Attinger-Toller A, Tanner F, Taramasso M, Corti R, Grünenfelder J, Lüscher T, Ruschitzka F, Bettex D, Maisano F, Gaemperli O

April 8, 2016 | 10.4244/EIJV11I14A320

Safety and feasibility of novel technology fusing echocardiography and fluoroscopy images during MitraClip interventions

Sündermann S, Biaggi P, Grünenfelder J, Gessat M, Felix C, Bettex D, Falk V, Corti R

February 20, 2014 | 10.4244/EIJV9I10A203

Integrated x-ray and echocardiography imaging for structural heart interventions

Corti R, Biaggi P, Gaemperli O, Bühler I, Felix C, Bettex D, Kretschmar O, Falk V, Grünenfelder J

November 29, 2013 | 10.4244/EIJV9I7A140

The 2011-12 pilot European Sentinel Registry of Transcatheter Aortic Valve Implantation: in-hospital results in 4,571 patients

Di Mario C, Eltchaninoff H, Moat N, Goicolea J, Ussia G, Kala P, Wenaweser P, Zembala M, Nickenig G, Barrero E, Snow T, Iung B, Zamorano P, Schuler G, Corti R, Alfieri O, Prendergast B, Ludman P, Windecker S, Sabaté M, Gilard M, Witkowski A, Danenberg H, Schröder E, Romeo F, Macaya C, Derumeaux G, Maggioni A, Tavazzi L

April 19, 2013 | 10.4244/EIJV8I12A209

The three year follow-up of the randomised “all-comers” trial of a biodegradable polymer biolimus-eluting stent versus permanent polymer sirolimus-eluting stent (LEADERS)

Wykrzykowska J, Serruys P, Buszman P, Linke A, Ischinger T, Klauss V, Eberli F, Corti R, Wijns W, Morice M, Di Mario C, van Geuns R, Van Es G-A, Jüni P, Windecker S

November 30, 2011 | 10.4244/EIJV7I7A125

Implantation of the biodegradable polymer biolimus-eluting stent in patients with high SYNTAX score is associated with decreased cardiac mortality compared to a permanent polymer sirolimus-eluting stent: two year follow-up results from the “all-comers” LEADERS trial

Wykrzykowska J, Garg S, Onuma Y, de Vries T, Morel M, Van Es G-A, Buszman P, Linke A, Ischinger T, Klauss V, Corti R, Eberli F, Wijns W, Morice M, Di Mario C, van Geuns R, Jüni P, Windecker S, Serruys P

September 30, 2011 | 10.4244/EIJV7I5A97

The outcome of bifurcation lesion stenting using a biolimuseluting stent with a bio-degradable polymer compared to a sirolimus-eluting stent with a durable polymer

Garg S, Wykrzykowska J, Serruys P, de Vries T, Buszman P, Trznadel S, Linke A, Lenk K, Ischinger T, Klauss V, Eberli F, Corti R, Wijns W, Morice M, Di Mario C, Tyczynski P, van Geuns R, Eerdmans P, Van Es G-A, Meier B, Jüni P, Windecker S

March 21, 2011

The twelve-month outcomes of a biolimus eluting stent with a biodegradable polymer compared with a sirolimus eluting stent with a durable polymer

Garg S, Sarno G, Serruys P, de Vries T, Buszman P, Linke A, Ischinger T, Klauss V, Eberli F, Corti R, Wijns W, Morice M, Di Mario C, van Geuns R, Eerdmans P, Van Es G-A, Meier B, Jüni P, Windecker S

June 30, 2010

Biolimus-eluting biodegradable polymer versus sirolimus-eluting permanent polymer stent performance in long lesions: results from the LEADERS multicentre trial substudy

Wykrzykowska J, Räber L, Ton de Vries T, Bressers M, Buszman P, Linke A, Ischinger T, Klauss V, Eberli F, Corti R, Wijns W, Morice M, Di Mario C, Regar E, Jüni P, Windecker S, Serruys P

August 14, 2009

Latest news

NEW ISSUE

Ischaemia with non-obstructive coronary arteries, OCT vs IVUS guidance in PCI; the ILUMIEN III and ILUMIEN IV trials…

Elective Cardiac Invasive Procedures during the COVID-19 Outbreak

A. Chieffo et al.

January 8, 2021

EDITORIAL

Smoke signals – do they help to predict TAVI-associated stroke risk?

R. Kharbanda et al.

January 25, 2021

Trials Book

SCOPE 2, BASKET-SMALL 2 3 years, ALPHEUS, COMPARE-ABSORB, DUBIUS

(Thanks to the support of Biotronik)

January 13, 2021

Guidance Papers

Guidelines, consensus & position papers

August 28, 2020

JAA

This Week's JAA's: Redo-TAVI, Major bleeding in the Amulet Observational Study, OCT findings in ESR...